Lv61
1770 积分 2022-08-08 加入
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation
2个月前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
2个月前
已完结
Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders
3个月前
已完结
Mitochondrial Quality Control in Cerebral Ischemia-Reperfusion Injury
3个月前
已完结
Contribution of Glucocorticoids and Glucocorticoid Receptors to the Regulation of Neurodegenerative Processes
3个月前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
3个月前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
3个月前
已完结
Low-dose tacrolimus in treating neuromyelitis optica spectrum disorder
3个月前
已完结
皖公网安备34019202002308
